Used primarily as a key intermediate in the synthesis of pharmaceutical compounds, especially in the development of kinase inhibitors for targeted cancer therapies. Its structure supports cross-coupling reactions via the boronate ester group, enabling efficient construction of complex drug molecules. Commonly employed in Suzuki-Miyaura coupling reactions during medicinal chemistry research to generate diverse analogs for structure-activity relationship studies. Its nitrile and sulfone functionalities enhance binding selectivity and metabolic stability in final active pharmaceutical ingredients. Widely applied in late-stage functionalization due to its compatibility with various reaction conditions, making it valuable in oncology drug discovery programs.